Clomipramine vs Desipramine Crossover Trial in Body Dysmorphic Disorder
Authors:
- Andrea AllenAAAndrea Allen
- Jee KwonJKJee Kwon
- Bonnie AronowitzBABonnie Aronowitz
- James SchmeidlerJSJames Schmeidler
- Cheryl WongCWCheryl Wong
- Daphne SimeonDSDaphne Simeon
Open Access
- 1 November 1999
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 56 (11) , 1033-1039
Abstract
Research from JAMA Psychiatry — Clomipramine vs Desipramine Crossover Trial in Body Dysmorphic Disorder — Selective Efficacy of a Serotonin Reuptake Inhibitor in Imagined UglinessKeywords
This publication has 6 references indexed in Scilit:
- Efficacy and Safety of Fluvoxamine in Body Dysmorphic DisorderThe Journal of Clinical Psychiatry, 1998
- Body dysmorphic disorder in the DSM-IV field trial for obsessive- compulsive disorderAmerican Journal of Psychiatry, 1995
- A survey of body dysmorphic disorder in plastic surgery patientsBiological Psychiatry, 1995
- Body dysmorphic disorder: 30 cases of imagined uglinessAmerican Journal of Psychiatry, 1993
- Treatment of body-dysmorphic disorder with serotonin reuptake blockersAmerican Journal of Psychiatry, 1989
- Measurement of social-evaluative anxiety.Journal of Consulting and Clinical Psychology, 1969